Maxim Group Lowers Oncolytics Biotech (NASDAQ:ONCY) Price Target to $3.00
Oncolytics Biotech (NASDAQ:ONCY – Get Free Report) had its target price lowered by investment analysts at Maxim Group from $5.00 to $3.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Maxim Group’s price target suggests a potential upside of 389.72% from the company’s previous […]
Oncolytics Biotech (NASDAQ:ONCY – Get Free Report) had its target price lowered by investment analysts at Maxim Group from $5.00 to $3.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Maxim Group’s price target suggests a potential upside of 389.72% from the company’s previous […]
